Aurobindo Pharma Buyback Opens at ₹1,475 Per Share for Up to 54,23,728 Equity Shares
Published on: April 23, 2026, 5:03 a.m. | Source: scanx.trade
Aurobindo Pharma Limited has commenced its buyback offer for up to 54,23,728 equity shares at ₹1,475 per share, aggregating to ₹800,00,00,000. The offer opened on April 23, 2026, and closes on April 29, 2026. Eligible shareholders include small shareholders with an entitlement of 7 equity shares out of every 61 held, and general category shareholders entitled to 2 equity shares out of every 249 held as on the record date of April 17, 2026. The letter of offer was dispatched electronically on April 21, 2026. Shareholders can check their entitlement through the registrar's website. Axis Capital Limited serves as the manager to the offer, while KFin Technologies Limited is the registrar.
